Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| JPMorgan Chase & Co.COMMON EQUITY(JPM) | 0 | 379,000 | +379,000 | $0 | $109.9K | 26.20% | +$109.9K |
| American Express CompanyCOMMON EQUITY(AXP) | 0 | 197,215 | +197,215 | $0 | $62.9K | 15.00% | +$62.9K |
| The Progressive CorporationCOMMON EQUITY(PGR) | 0 | 182,000 | +182,000 | $0 | $48.6K | 11.58% | +$48.6K |
| Mastercard IncorporatedCOMMON EQUITY(MA) | 0 | 68,000 | +68,000 | $0 | $38.2K | 9.11% | +$38.2K |
| Berkshire Hathaway Inc Cl ACOMMON EQUITY | 0 | 44 | +44 | $0 | $32.1K | 7.65% | +$32.1K |
| U.S. BancorpCOMMON EQUITY(USB) | 0 | 558,000 | +558,000 | $0 | $25.2K | 6.02% | +$25.2K |
| Western Alliance BancorporationCOMMON EQUITY(WAL) | 0 | 285,000 | +285,000 | $0 | $22.2K | 5.30% | +$22.2K |
| The Goldman Sachs Group, Inc.COMMON EQUITY(GS) | 0 | 25,000 | +25,000 | $0 | $17.7K | 4.22% | +$17.7K |
| Aon plcCOMMON EQUITY(AON) | 0 | 49,000 | +49,000 | $0 | $17.5K | 4.17% | +$17.5K |
| Arch Capital Group LtdCOMMON EQUITY ORD | 0 | 150,000 | +150,000 | $0 | $13.7K | 3.26% | +$13.7K |
| KKR & Co. Inc.COMMON EQUITY(KKR) | 0 | 91,000 | +91,000 | $0 | $12.1K | 2.89% | +$12.1K |
| Alibaba Group Holding LimitedCOMMON EQUITY(BABA) | 0 | 50,000 | +50,000 | $0 | $5.7K | 1.35% | +$5.7K |
| Global Payments Inc.COMMON EQUITY(GPN) | 0 | 68,000 | +68,000 | $0 | $5.4K | 1.30% | +$5.4K |
| Accenture Plc Cl ACOMMON EQUITY SHS CLASS A | 0 | 15,000 | +15,000 | $0 | $4.5K | 1.07% | +$4.5K |
| Northern Trust CorporationCOMMON EQUITY(NTRS) | 0 | 30,000 | +30,000 | $0 | $3.8K | 0.91% | +$3.8K |
| Bank OZKCOMMON EQUITY(OZK) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Citigroup Inc.COMMON EQUITY(C) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Cadence BancorpCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Wells Fargo & CompanyCOMMON EQUITY(WFC) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| The Charles Schwab CorporationCOMMON EQUITY(SCHW) | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Amryt Pharma Ltd - Spnr AdrCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Atai Lifesciences NvCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |
| Kaleyra IncCOMMON EQUITY | 0 | 0 | 0 | $0 | $0 | — | $0 |